Advances in computational structure-based antibody design

Abstract excerpt

Antibodies are currently the most important class of biotherapeutics and are used to treat numerous diseases. Recent advances in computational methods are ushering in a new era of antibody design, driven in part by accurate structure prediction. Previously, structure-based antibody design has been limited to a relatively small number of cases where accurate structures or models of both the target antigen and...

Topics

Join the communities discussing this publication.

• Glycosylation and Glycoproteins Research
• Monoclonal and Polyclonal Antibodies Research
• Transgenic Plants and Applications